LSP1

Across TCGA pan-cancer cohorts, LSP1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LSP1 data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher LSP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LSP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ESCA, LUAD, and KIRP are the cancer types where LSP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.166	0.707	<.001	33	view →
LUAD	DFS	Median	All	0.235	0.667	.001	30	view →
KIRP	OS	Median	II,III,IV	0.148	0.771	<.001	27	view →
UCEC	DFS	Median	All	0.951	0.628	.027	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LSP1–ESCA (OS)

Open the ESCA breakdown →